Skip to main content

Table 3 Antibiotic resistance pattern of the biofilm producing and non producing Uropathogenic E. coli

From: Biofilm formation, antimicrobial susceptibility, serogroups and virulence genes of uropathogenic E. coli isolated from clinical samples in Iran

Antibiotic

Biofilm producer (N = 80)

Non biofilm producer (N = 50)

Resistance

Sensitive

Resistance

Sensitive

Ampicillin (AM)

70 (87.5 %)

10 (12.5 %)

40 (80 %)

10 (20 %)

Tetracycline (TE)

60 (75 %)

20 (25 %)

35 (70 %)

15 (30 %)

Nalidixic Acid (NA)

58 (72.5 %)

22 (27.5 %)

34 (68 %)

16 (32 %)

Co-Trimoxazole (SXT)

57 (71.25 %)

23 (28.75 %)

33 (66 %)

17 (34 %)

Cephalothin (CF)

45 (56.25 %)

35 (43.75 %)

28 (56 %)

22 (44 %)

Ciprofloxacin (CP)

45 (56.25 %)

35 (43.75 %)

27 (54 %)

23 (46 %)

Norfloxacin (NOR)

43 (53.75 %)

37 (46.25 %)

26 (52 %)

24 (48 %)

Ceftriaxone (CRO)

33 (41.25 %)

47 (58.75 %)

20 (40 %)

30 (60 %)

Amikacin (AN)

31 (38.75 %)

49 (61.25 %)

18 (36 %)

32 (64 %)

Imipenem (IMP)

25 (31.25 %)

55 (68.75 %)

15 (30 %)

35 (70 %)

Gentamicin (GM)

15 (18.75 %)

65 (81.25 %)

9 (18 %)

41 (82 %)

Nitrofurantoin (FM)

5 (6.25 %)

75 (93.75 %)

1 (2 %)

49 (98 %)

Back to article page

Antimicrobial Resistance & Infection Control

ISSN: 2047-2994

Contact us